Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: Epidemiological studies in a nonbiased national cohort in Sweden

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages 1425-1432

  Strandqvist, A ^a,b   Falhammar, H ^a,b   Lichtenstein, P ^b   Hirschberg, A L ^b   Wedell, A ^a,b   Norrby, C ^b   Nordenskjold A ^a,b   Frisen L ^b   Nordenstrom A ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; PSYCHOLOGY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STEROID 21-HYDROXYLASE; SWEDEN; YOUNG ADULT;

EID: 84898490289     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3326     Document Type: Article

References (35)

1. White PC, BachegaTASS. Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood. Semin. Reprod. Med. 2012;30:400-409.
2. Gidlof S, Falhammar H, Thilen A, Wedell A, et al. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. Lancet Diabetes, Endocrinology Elsevier; 2013;1(34):35-42.
3. Falhammar H, Thoren M. Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine. 2012;41:355-373.
4. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365:2125-2136.
5. Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4133-4160.
6. Merke DP, Chrousos GP, Eisenhofer G, et al. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. NEngl J Med. 2000;343:1362-1368.
7. Han TS, Krone N, Willis DS, et al. Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). Eur J Endocri-nol. 2013;168:887-893.
8. Nordenskjold A, Holmdahl G, Frisen L, et al. Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. JClin Endocrinol Metab. 2008;93: 380-386.
9. Braga LH, Pippi Salle JL. Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment. Eur J Pediatr Surg. 2009;19:203-210.
10. Nordenstrom A, Frisen L, Falhammar H, et al. Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception. J. Clin. Endocrinol. Metab. 2010;95:3633-3640.
11. Nordenstrom A. Adult women with 21-hydroxylase deficient congenital adrenal hyperplasia, surgical and psychological aspects. Curr Opin Pediatr. 2011;23:436-442.
12. Nordenstrom A, Servin A, Bohlin G, Larsson A, Wedell A. Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2002;87:5119-5124.
13. Pasterski V, Hindmarsh P, Geffner M, Brook C, Brain C, Hines M. Increased aggression and activity level in 3-to 11-year-old girls with congenital adrenal hyperplasia (CAH). Horm Behav. 2007;52:368-374.
14. Hines M, Kaufman FR. Androgen and the development of human sex-typical behavior: rough-and-tumble play and sex of preferred playmates in children with congenital adrenal hyperplasia (CAH). Child Dev. 1994;65:1042-1053.
15. Frisen L, Nordenstrom A, Falhammar H, et al. Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J Clin Endo-crinol Metab. 2009;94:3432-3439.
16. Meyer-Bahlburg HFL, Dolezal C, Baker SW, New MI. Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch Sex Behav. 2008;37:85-99.
17. Berenbaum SA, Duck SC, Bryk K. Behavioral effects of prenatal versus postnatal androgen excess in children with 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2000;85:727-733.
18. Berenbaum SA, Korman Bryk K, Duck SC, Resnick SM. Psychological adjustment in children and adults with congenital adrenal hyperplasia. J. Pediatr. 2004;144:741-746.
19. Arlt W, Willis DS, Wild SH, et al. Health status of adults with congenital adrenal hyperplasia: a cohort studyof203 patients. JClin Endocrinol Metab. 2010;95:5110-5121.
20. Johannsen TH, Ripa CPL, Mortensen EL, Main KM. Quality oflife in 70 women with disorders of sex development. Eur JEndocrinol. 2006;155:877-885.
21. Nermoen I, Husebye ES, Svartberg J, Lovas K. Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur J Endocrinol. 2010;163: 453-459.
22. Kuhnle U, Bullinger M. Outcome of congenital adrenal hyperplasia. Pediatr Surg Int. 1997;12:511-515.
23. Wisniewski AB, Migeon CJ, Malouf MA, Gearhart JP. Psychosex-ual outcome in women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Urol. 2004;171:2497-2501.
24. Gastaud F, Bouvattier C, Duranteau L, et al. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2007;92:1391-1396.
25. Malouf MA, Inman AG, Carr AG, Franco J, Brooks LM. Health-related quality of life, mental health and psychotherapeutic considerations for women diagnosed with a disorder of sexual development: congenital adrenal hyperplasia. Int J Pediatr Endocrinol. 2010;2010:253465.
26. Falhammar H, Nystrom HF, Ekstrom U, Granberg S, Wedell A, Thoren M. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur JEndocrinol. 2012;166:441-449.
27. Casteras A, De Silva P, Rumsby G, Conway GS. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf). 2009;70:833-837.
28. Hagenfeldt K, Janson PO, Holmdahl G, et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod. 2008;23:1607-1613.
29. Wedell A. Molecular genetics of 21-hydroxylase deficiency. Endocr Dev. 2011;20:80-87.
30. Krone N, Rose IT, Willis DS, et al. Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE) Cohort. J Clin Endocrinol Metab. 2013;98:E346-E354.
31. Wedell A, Ritzen EM, Haglund-Stengler B, Luthman H. Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc Natl Acad Sci USA. 1992;89:7232-7236.
32. Johannsen TH. Impaired cognitive function in women with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2006;91: 1376-1381.
33. Het S, Ramlow G, Wolf OT. A meta-analytic review of the effects of acute cortisol administration on human memory. Psychoneu-roendocrinology. 2005;30(8):771-784.
34. Leveroni CL, Berenbaum SA. Early androgen effects on interest in infants: evidence from children with congenital adrenal hyperplasia. Dev Neuropsychol. 1998;14:321-341.
35. Jaaskelainen J, Voutilainen R. Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr. 2007;89:183-187.